Back to top
more

Treace Medical Concepts (TMCI)

(Delayed Data from NSDQ)

$6.65 USD

6.65
1,332,443

+0.01 (0.15%)

Updated Jun 28, 2024 04:00 PM ET

After-Market: $6.66 +0.01 (0.15%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (162 out of 249)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for Treace Medical Concepts, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 123 81 106 18 0
Receivables 38 29 19 14 0
Notes Receivable 0 0 0 0 0
Inventories 29 19 11 8 0
Other Current Assets 8 4 3 1 0
Total Current Assets 198 133 138 41 0
Net Property & Equipment 22 15 3 1 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 22 0 0 0 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 252 159 141 42 0
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 12 9 4 2 0
Current Portion Long-Term Debt 0 0 0 2 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 29 21 14 8 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 4 0 0 0 0
Total Current Liabilities 45 30 18 12 0
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 53 53 30 29 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 114 99 48 41 0
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 8 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 272 145 135 14 0
Retained Earnings -134 -85 -42 -21 0
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 138 61 93 1 0
Total Liabilities & Shareholder's Equity 252 159 141 42 0
Total Common Equity 138 61 93 -7 0
Shares Outstanding 61.60 55.50 53.10 NA NA
Book Value Per Share 2.24 1.09 1.75 0.00 0.00

Fiscal Year End for Treace Medical Concepts, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 110 123 122 139 171
Receivables 30 38 25 27 25
Notes Receivable 0 0 0 0 0
Inventories 36 29 29 26 23
Other Current Assets 11 8 11 5 5
Total Current Assets 187 198 187 198 223
Net Property & Equipment 25 22 22 19 16
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 22 22 22 22 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 243 252 240 250 249
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 21 12 9 8 5
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 25 29 19 18 17
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 4 5 4 0
Total Current Liabilities 47 45 33 30 23
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 53 53 53 53 53
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 116 114 103 100 92
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 279 272 266 261 256
Retained Earnings -153 -134 -128 -110 -98
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 126 138 138 150 158
Total Liabilities & Shareholder's Equity 243 252 240 250 249
Total Common Equity 126 138 138 150 158
Shares Outstanding 61.70 61.60 61.50 61.30 61.20
Book Value Per Share 2.05 2.24 2.24 2.45 2.58